Barclays' passive stake adds institutional credibility but does not signal activist intent. Monitor for any future 13D conversion or additional accumulation by Barclays or other large holders.
ALDX drugs
ALDX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $0.6337entry
- T+1 · 8d ago +0.36%α −2.00% · $0.6360
- T+5 · 4d ago +1.59%α −1.00% · $0.6438
- T+7 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Barclays PLC disclosed a 5.48% passive stake in Aldeyra Therapeutics via a Schedule 13G filed November 6, 2026, representing 3,310,587 common shares held as of September 30, 2026. This is a new passive filer for Aldeyra, adding to prior 13G filings by AQR Capital Management, Perceptive Advisors, and Vanguard Group.
Key Financial Metrics
Key Facts
- Barclays PLC reported beneficial ownership of 3,310,587 common shares of Aldeyra Therapeutics
- Stake represents 5.48% of shares outstanding as of September 30, 2026
- Filing is a new Schedule 13G (not an amendment), certifying passive intent under Rule 13d-1(b)
- Barclays is a new 5%+ filer for Aldeyra; prior 13G filers include AQR Capital Management, Perceptive Advisors, and Vanguard Group
Financial Impact
3,310,587 shares valued at approximately $2.1M based on $39M market cap and 5.48% stake
Risk Factors
- No stated intent to influence management or strategy
- Passive stake could be reduced or exited without public notice
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000312069-26-000249 |
| Document: 0000312069-26-000249-index.html | 0000312069-26-000249 |
| Document: 0000312069-26-000249.txt | 0000312069-26-000249 |
Track record
12 reports on ALDX
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +59.67% at T+60 after the Aug 16, 2026 report. 3 of 6 went positive at some point.
Filters
- Nov 17, 2026today 8-K Bearish 7/10 Entry $0.6799 Now $0.6939 −2.06% settles Dec 17
- Nov 13, 20264d ago Insider Cluster Neutral 4/10 Entry $0.6696 Now $0.6939 +3.63% settles Dec 15
- Nov 12, 20265d ago SC 13G/A Bearish 5/10 Entry $0.6301 Now $0.6939 −10.13% settles Dec 11
- Nov 9, 20268d ago 8-K Bearish 6/10 Entry $0.6291 Now $0.6939 −10.30% settles Dec 9
- Nov 6, 202611d ago SC 13G Neutral 3/10 Viewing Entry $0.6337 Now $0.6939 +9.50% settles Dec 7
- Nov 4, 202613d ago Institutional Cluster Bearish 4/10 Entry $0.6474 Now $0.6939 −7.18% settles Dec 3
- Sep 29, 20267w ago 8-K Bullish 7/10 Entry $1.32 to $0.6412 Now $0.6939 −47.43% ▼ −51.42% −52.14% vs SPY
- Aug 16, 202613w ago Institutional Cluster Bearish 6/10 Entry $1.56 to $1.37 Now $0.6939 +55.52% ▲ +12.18% +10.20% vs SPY
- Jul 30, 202615w ago 8-K Neutral 2/10 Entry $1.54 to $1.49 Now $0.6939 −54.94% ▼ −3.57% −6.56% vs SPY
- Apr 27, 202629w ago DEFA14A Neutral 2/10 Entry $1.57 to $1.78 Now $0.6939 −55.80% ▲ +13.38% +7.91% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers